Pulsar Helium Appoints Cliff Cain as Manager of Commercial and External Affairs and Announces Completion of Jetstream #4 with Increased Bottom-Hole Pressure

Pulsar Helium Appoints Cliff Cain as Manager of Commercial and External Affairs and Announces Completion of Jetstream #4 with Increased Bottom-Hole Pressure GlobeNewswire November 26, 2025 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM […]

YEAHKA Accelerates Overseas Business Expansion in Q3, Building One-Stop Customer Loyalty Solutions for Brand Clients Such as PlayMade and Jumbo

YEAHKA LIMITED issued a voluntary announcement.It indicates that in the third quarter of 2025, the company's overseas business continues to maintain rapid growth with the gross payment value (GPV) of overseas business reached approximately RMB 1.3 billion, surpassing the full-year overseas GPV in 2024. Moreover, Yeahka's one-stop payment and value-added services continued to support international

The Rise of Cloud Phones: How GeeLark Is Redefining Social Media Marketing

In the past decade, social media marketing has undergone one transformation after another – from desktop-driven campaigns to mobile-first content, from post scheduling to algorithm-driven engagement strategies. Yet, even as the industry evolves, one critical gap has remained: marketers are still relying on desktop-based tools to manage platforms that were designed for mobile.GeeLark, a next-generation

Curasight’s uTREAT® Phase 1 Trial in Brain Cancer Now Open for Patient Enrollment

— Phase 1 study in aggressive brain cancer (Glioblastoma) is the first clinical trial investigation of uTREAT® — Site given green light by European Medicines Agency (EMA) and is now open for patient enrollment – first patient dosing expected Q4 2025 — Both arms of Curasight's theranostic approach investigating better treatment (uTREAT®) and diagnosis (uTRACE®)

Celltrion announces publication of post-hoc analysis of LIBERTY-CD study of ZYMFENTRA® (infliximab-dyyb), indicating consistent efficacy across disease location, including the terminal ileum in Clinical Gastroenterology and Hepatology journal

— Findings from the post-hoc analysis of LIBERTY-CD study indicates efficacy ofZYMFENTRA® (subcutaneous infliximab) regardless of disease location, consistent across ileum-dominant and colon-dominant Crohn's disease (CD) — Findings support the therapeutic potential ofZYMFENTRA in addressing persistent treatment gaps especially in ileum-dominant CD Celltrion, Inc. today announced that a post-hoc analysis of the LIBERTY-CD study, which

Trusted Crypto Casinos 2025: Jackbit Recognized in the Bitcoin Casino Space for Its No-KYC Policy and 30% Rakeback Feature

Trusted Crypto Casinos 2025: Jackbit Recognized in the Bitcoin Casino Space for Its No-KYC Policy and 30% Rakeback Feature JACKBIT advances the field of the most popular crypto casinos by prioritizing quick fund movements and user data protection in online crypto casinos. GlobeNewswire November 26, 2025 Maryland, US, , Nov. 26, 2025 (GLOBE NEWSWIRE) —

Nyxoah’s Genio(R) Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

(Brussels:NYXH),(NasdaqGM:NYXH), Nyxoah's Genio(R) Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule Assignment to New Technology APC 1580 is positive news for Nyxoah's U.S. commercial rollout by strengthening hospital and ASC economics Mont-Saint-Guibert, Belgium – November 26, 2025, 7:45 am CET / 1:45 am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or

Vital Signs highlights how researchers are “cracking the code on the genome” to harness the biomedical superpowers of hibernating animals

In a groundbreaking new episode, CNN's long-running series Vital Signsdelves into the cutting-edge science of hibernation, revealing how the secrets of the animal kingdom could unlock revolutionary advancements in human health, from fighting cancer and heart disease to facilitating space travel. This November, CNN's Chief Medical Correspondent, Dr. Sanjay Gupta, takes viewers on a global

Scroll to Top